{
     "PMID": "23011134",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20130201",
     "LR": "20170922",
     "IS": "2041-1723 (Electronic) 2041-1723 (Linking)",
     "VI": "3",
     "DP": "2012",
     "TI": "Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.",
     "PG": "1080",
     "LID": "10.1038/ncomms2045 [doi]",
     "AB": "Fragile X syndrome, the most commonly known genetic cause of autism, is due to loss of the fragile X mental retardation protein, which regulates signal transduction at metabotropic glutamate receptor-5 in the brain. Fragile X mental retardation protein deletion in mice enhances metabotropic glutamate receptor-5-dependent long-term depression in the hippocampus and cerebellum. Here we show that a distinct type of metabotropic glutamate receptor-5-dependent long-term depression at excitatory synapses of the ventral striatum and prefrontal cortex, which is mediated by the endocannabinoid 2-arachidonoyl-sn-glycerol, is absent in fragile X mental retardation protein-null mice. In these mutants, the macromolecular complex that links metabotropic glutamate receptor-5 to the 2-arachidonoyl-sn-glycerol-producing enzyme, diacylglycerol lipase-alpha (endocannabinoid signalosome), is disrupted and metabotropic glutamate receptor-5-dependent 2-arachidonoyl-sn-glycerol formation is compromised. These changes are accompanied by impaired endocannabinoid-dependent long-term depression. Pharmacological enhancement of 2-arachidonoyl-sn-glycerol signalling normalizes this synaptic defect and corrects behavioural abnormalities in fragile X mental retardation protein-deficient mice. The results identify the endocannabinoid signalosome as a molecular substrate for fragile X syndrome, which might be targeted by therapy.",
     "FAU": [
          "Jung, Kwang-Mook",
          "Sepers, Marja",
          "Henstridge, Christopher M",
          "Lassalle, Olivier",
          "Neuhofer, Daniela",
          "Martin, Henry",
          "Ginger, Melanie",
          "Frick, Andreas",
          "DiPatrizio, Nicholas V",
          "Mackie, Ken",
          "Katona, Istvan",
          "Piomelli, Daniele",
          "Manzoni, Olivier J"
     ],
     "AU": [
          "Jung KM",
          "Sepers M",
          "Henstridge CM",
          "Lassalle O",
          "Neuhofer D",
          "Martin H",
          "Ginger M",
          "Frick A",
          "DiPatrizio NV",
          "Mackie K",
          "Katona I",
          "Piomelli D",
          "Manzoni OJ"
     ],
     "AD": "Department of Anatomy and Neurobiology, University of California, Irvine, California 92697, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "DA-021696/DA/NIDA NIH HHS/United States",
          "DA-011322/DA/NIDA NIH HHS/United States",
          "R01 DA012447/DA/NIDA NIH HHS/United States",
          "R01 DA011322/DA/NIDA NIH HHS/United States",
          "243153/European Research Council/International",
          "DA-012447/DA/NIDA NIH HHS/United States",
          "K05 DA021696/DA/NIDA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "Nat Commun",
     "JT": "Nature communications",
     "JID": "101528555",
     "RN": [
          "0 (Arachidonic Acids)",
          "0 (Endocannabinoids)",
          "0 (Fmr1 protein, mouse)",
          "0 (Glycerides)",
          "0 (Receptor, Metabotropic Glutamate 5)",
          "0 (Receptors, Metabotropic Glutamate)",
          "139135-51-6 (Fragile X Mental Retardation Protein)",
          "8D239QDW64 (glyceryl 2-arachidonate)",
          "EC 3.1.1.34 (Lipoprotein Lipase)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Arachidonic Acids/*metabolism",
          "Endocannabinoids/*metabolism",
          "Fragile X Mental Retardation Protein/genetics/metabolism",
          "Fragile X Syndrome/genetics/*metabolism",
          "Glycerides/*metabolism",
          "Lipoprotein Lipase/genetics/*metabolism",
          "Male",
          "Mice",
          "Mice, Knockout",
          "Receptor, Metabotropic Glutamate 5",
          "Receptors, Metabotropic Glutamate/genetics/*metabolism",
          "Signal Transduction/genetics/physiology"
     ],
     "PMC": "PMC3657999",
     "EDAT": "2012/09/27 06:00",
     "MHDA": "2013/02/05 06:00",
     "CRDT": [
          "2012/09/27 06:00"
     ],
     "PHST": [
          "2012/04/10 00:00 [received]",
          "2012/08/01 00:00 [accepted]",
          "2012/09/27 06:00 [entrez]",
          "2012/09/27 06:00 [pubmed]",
          "2013/02/05 06:00 [medline]"
     ],
     "AID": [
          "ncomms2045 [pii]",
          "10.1038/ncomms2045 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Nat Commun. 2012;3:1080. doi: 10.1038/ncomms2045.",
     "term": "hippocampus"
}